Orchid Pharma Q3 net loss narrows to Rs 60.97 cr
Press Trust of India New Delhi Drug firm Orchid Pharma's standalone net loss narrowed to Rs 60.97 crore during the quarter ended December 31, 2016.
The company had posted a net loss of Rs 94.02 crore in the year-ago period, Orchid Pharma said in a BSE filing.
Its standalone total income from operations also declined to Rs 179.98 crore during the quarter under review from Rs 205.87 crore a year ago.
Shares of Orchid Pharma today closed 2.47 per cent down at Rs 29.65 ascrip on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content